Mankind Pharma, the 4th largest pharmaceutical company in India has launched Justoza, a Dapagliflozin brand marketed by Mankind to treat Diabetes, Heart Failure and Chronic Kidney Disease.The Active Pharmaceutical Ingredient is procured from DMF facility approved by USFDA, EU GMP and WHO GMP, which ensures highest global efficacy and safety standards. It is believed that quality of DMF grade facility product is of highest standard in terms of safety and efficacy.DMF (Drug Master File) is an important confidential document submitted to USFDA by a manufacturer in order to get approval for exporting pharmaceutical drugs and its ingredients to US market. Drug Master File (DMF) provides necessary documentation to regulatory agencies to prove that the manufacturing facility satisfies the quality and safety requirements of USFDA and other regulatory bodies across world. FDA ensures that the drug substance which is subject of the DMF is of the best quality.
